| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
9e-07 |
| mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-05 |
| mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |